Lasmiditan: all 32 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Study to Compare Two Different Formulations of Lasmiditan in Healthy ParticipantsCompletedNCT04881747Phase 1Results posted
• A Study of Lasmiditan in Healthy VolunteersCompletedNCT04749914Phase 1Results posted
• A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminatedNCT04396574Phase 3Results posted
• A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With MigraineTerminatedNCT04396236Phase 3Results posted
• A Study of Lasmiditan in Healthy Chinese ParticipantsCompletedNCT04081324Phase 1Results posted
• A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With MigraineCompletedNCT03988088Phase 1Results posted
• A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With MigraineCompletedNCT03962738Phase 2Results posted
• A Study of Lasmiditan (LY573144) Over Four Migraine AttacksCompletedNCT03670810Phase 3Results posted
• A Study of Lasmiditan in Healthy Japanese and Caucasian ParticipantsCompletedNCT03579940Phase 1Results posted
• A Study of Lasmiditan on the Heart in Healthy ParticipantsCompletedNCT03465436Phase 1Results posted
• A Study of Lasmiditan on Simulated Driving Performance in Healthy ParticipantsCompletedNCT03459612Phase 1Results posted
• A Study of Lasmiditan in Healthy Elderly ParticipantsCompletedNCT03406260Phase 1Results posted
• A Study of Lasmiditan When Given With Sumatriptan in Healthy ParticipantsCompletedNCT03310411Phase 1Results posted
• A Study of Lasmiditan in Healthy Participants When Co-administered With TopiramateCompletedNCT03308669Phase 1Results posted
• A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug UsersCompletedNCT03286218Phase 1Results posted
• A Study of Lasmiditan and Propranolol in Healthy ParticipantsCompletedNCT03270644Phase 1Results posted
• A Study of Multiple Doses of Lasmiditan in Healthy ParticipantsCompletedNCT03252015Phase 1Results posted
• A Study of Lasmiditan in Participants With MigraineCompletedNCT03247790Phase 1Results posted
• A Study of Lasmiditan in Healthy ParticipantsCompletedNCT03182920Phase 1Results posted
• Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy ParticipantsCompletedNCT03076970Phase 1Results posted
• Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic FunctionCompletedNCT03040479Phase 1Results posted
• Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose AdministrationCompletedNCT03040362Phase 1Results posted
• The Effects of Lasmiditan on Simulated Driving Performance - Healthy ParticipantsCompletedNCT03012334Phase 1Results posted
• Study of Oral Lasmiditan in Participants With Normal and Impaired Renal FunctionCompletedNCT03009162Phase 1Results posted
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of MigraineCompletedNCT02605174Phase 3Results posted
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of MigraineCompletedNCT02565186Phase 3Results posted
• Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:CompletedNCT02439320Phase 3Results posted
• Food-Effect Study in Healthy ParticipantsCompletedNCT02233296Phase 1Results posted
• Dose-ranging Study of Oral COL-144 in Acute Migraine TreatmentCompletedNCT00883051Phase 2Results posted
• A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of MigraineCompletedNCT00384774Phase 2Results posted
• Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in KoreanCompletedNCT04218162Phase 3
• Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy VolunteersStatus unknownNCT03937648Phase 1

← Lasmiditan overview